We are live on
!
Find out more
HWM
HighMark Wealth Management Portfolio holdings
AUM
$246M
1-Year Est. Return
35.95%
This Fund
S&P 500
This Quarter
Est. Return
+25.96%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$91M
AUM Growth
+$8.18M
(+9.9%)
Cap. Flow
-$8.22M
Cap. Flow
% of AUM
-9.03%
Top 10 Holdings %
Top 10 Hldgs %
77.23%
Holding
461
New
74
Increased
130
Reduced
52
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$2.32M |
| 2 |
Krystal Biotech
KRYS
|
+$836K |
| 3 |
CareDx
CDNA
|
+$470K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$407K |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$359K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$13M |
| 2 |
QuidelOrtho
QDEL
|
+$272K |
| 3 |
Thermo Fisher Scientific
TMO
|
+$165K |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$139K |
| 5 |
DexCom
DXCM
|
+$119K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.05% |
| 2 | Technology | 2.45% |
| 3 | Financials | 1.96% |
| 4 | Industrials | 1.54% |
| 5 | Consumer Discretionary | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Ulta Beauty
ULTA
$21.8B
| – | – |
-9
| Closed | -$1K |
|
452
Vanguard Small-Cap ETF
VB
$78.9B
| – | – |
-205
| Closed | -$23K |
|
453
Vanguard FTSE Developed Markets ETF
VEA
$223B
| $0 | ﹤0.01% |
11
+1
| +10% | +$37 |
|
454
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $0 | ﹤0.01% |
7
| – | – |
|
455
Wabtec
WAB
$49.3B
| $0 | ﹤0.01% |
2
| – | – |
|
456
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
| – | – |
-92
| Closed | -$3K |
|
|
BPY
457
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| – | – |
-99
| Closed | – |
|
|
AKRX
458
DELISTED
Akorn Inc
AKRX
| – | – |
-1,955
| Closed | -$1K |
|
|
KEM
459
DELISTED
KEMET Corporation
KEM
| – | – |
-87
| Closed | -$2K |
|
|
CEO
460
DELISTED
CNOOC Limited
CEO
| $0 | ﹤0.01% |
3
| – | – |
|
|
PLM
461
DELISTED
PolyMet Mining Corp.
PLM
| – | – |
-16,620
| Closed | -$39K |
|
Similar funds
PPA
IRP
EPIM
MAMHA
RPCONE
CSC
NTCM
VPA
HighMark Wealth Management's Q2 2020 Portfolio in Review
As of Q2 2020, HighMark Wealth Management held 461 positions worth $91M, up 9.9% from $82.9M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
HighMark Wealth Management withdrew a net $8.22M in Q2 2020, closing 24 positions and reducing 52 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $104K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.2% a quarter earlier, followed by Technology and Financials.
Against the trend, HighMark Wealth Management opened a new position in Immunomedics Inc worth $2.81M.
- HighMark Wealth Management's largest Q2 2020 buy was Immunomedics Inc: 79,422 shares worth $2.81M.
- HighMark Wealth Management added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $407K increase.
- HighMark Wealth Management's biggest Q2 2020 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $13M.
- HighMark Wealth Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, selling an estimated $104K.
- HighMark Wealth Management's ten largest holdings make up 77% of its $91M portfolio in Q2 2020.
- HighMark Wealth Management opened 74 new positions and closed 24 in Q2 2020.
- HighMark Wealth Management's portfolio value rose 9.9% quarter-over-quarter to $91M.
Based on HighMark Wealth Management's 13F filing for Q2 2020, filed 22 Jul 2020.